PF Equity Holdings 2 B.V. - 10 Sep 2021 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
10%+ Owner
Signature
Susan E. Grant, Attorney-in-fact on behalf of PF Equity Holdings 2 B.V.
Issuer symbol
ALLO
Transactions as of
10 Sep 2021
Net transactions value
$0
Form type
3
Filing time
20 Sep 2021, 18:25:59 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALLO Common Stock 22,032,040 10 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired from its parent entity, Pfizer Inc. for no cash consideration.

Remarks:

poa2n.htm